DIN 02411393 — ILEVRO 0.3 %
ILEVRO is a suspension of Nepafenac marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Nepafenac monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02411393
- Brand name
- ILEVRO
- Active ingredient
- Nepafenac
- Strength
- 0.3 %
- Dosage form
- SUSPENSION
- Route
- OPHTHALMIC
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Nonsteroidal anti-inflammatory drug (NSAID) - ophthalmic prodrug
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nepafenac products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02308983 | NEVANAC | 0.1 % | SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |